Opus Genetics, Inc. announced that three abstracts concerning its investigational gene therapy candidates will be presented at the ARVO 2025 Meeting in Salt Lake City, UT, from May 4-8, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback